TY - JOUR
T1 - Prevention of onychomycosis reinfection for patients with complete cure of all 10 toenails
T2 - Results of a double-blind, placebo-controlled, pilot study of prophylactic miconazole powder 2%
AU - Warshaw, Erin M.
AU - St Clair, Katherine R.
N1 - Funding Information:
Funding source: Coloplast Corp, Skin Health Division, through a generous, unrestricted research grant. Dr Warshaw's career has been supported by a VA Cooperative Studies Clinical Research Career Development Grant.
PY - 2005/10
Y1 - 2005/10
N2 - The objective of this 2-year, double-blind, placebo-controlled, randomized trial involving 48 participants was to determine if biweekly miconazole powder prevents onychomycosis recurrence. Intent-to-treat analysis found no significant differences in mycologic, clinical, or complete onychomycosis reinfection rates or time to reinfection. Limitations include small sample size and dosing regimen.
AB - The objective of this 2-year, double-blind, placebo-controlled, randomized trial involving 48 participants was to determine if biweekly miconazole powder prevents onychomycosis recurrence. Intent-to-treat analysis found no significant differences in mycologic, clinical, or complete onychomycosis reinfection rates or time to reinfection. Limitations include small sample size and dosing regimen.
UR - http://www.scopus.com/inward/record.url?scp=25844474480&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=25844474480&partnerID=8YFLogxK
U2 - 10.1016/j.jaad.2005.06.019
DO - 10.1016/j.jaad.2005.06.019
M3 - Article
C2 - 16198805
AN - SCOPUS:25844474480
VL - 53
SP - 717
EP - 720
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
SN - 0190-9622
IS - 4
ER -